205
Views
4
CrossRef citations to date
0
Altmetric
Symposium: Patching, Drugs, or Lasik? Amblyopia Treatment in the 21st Century

Evidence-Based Amblyopia Treatment: Results of PEDIG Studies

, M.D., M.P.H.
Pages 48-55 | Published online: 22 Dec 2017

References

  • Holmes JM, Beck RW, Repka MX, et al: The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol 2001; 119: 1345–1353.
  • PPediatric Eye Disease Investigator Group: Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology 2006; 113: 895–903.
  • PPediatric Eye Disease Investigator Group: A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology 2006; 113: 904–912.
  • PPediatric Eye Disease Investigator Group: A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003; 110: 2075–2087.
  • PPediatric Eye Disease Investigator Group: A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003; 121: 603–611.
  • PPediatric Eye Disease Investigator Group: Risk of amblyopia recurrence after cessation of treatment. J AAPOS 2004; 8: 420–428.
  • PPediatric Eye Disease Investigator Group: Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 2005; 123: 437–447.
  • PPediatric Eye Disease Investigator Group: A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002; 120: 268–278.
  • PPediatric Eye Disease Investigator Group: Two-year follow-up of a 6-month randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2005; 123: 149–157.
  • PPediatric Eye Disease Investigator Group: A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology 2004; 111: 2076–2085.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.